Patient Guide: A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 119 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06131372
Status: ACTIVE_NOT_RECRUITING
Condition: Chronic Kidney Disease, Type 2 Diabetes, Obesity
Phase: PHASE2

Find a Study Location Near You

This study is available at 119 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Concord, California
  • Palm Springs, California
  • San Dimas, California
  • • And 116 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily